NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,777,534 | -62.7% | 110,064 | -4.0% | 0.00% | -63.6% |
| Q2 2023 | $4,760,342 | -33.0% | 114,707 | -2.8% | 0.01% | -31.2% |
| Q1 2023 | $7,100,729 | -18.0% | 118,070 | 0.0% | 0.02% | -23.8% |
| Q4 2022 | $8,660,435 | -6.3% | 118,070 | -3.0% | 0.02% | -12.5% |
| Q3 2022 | $9,244,000 | +8.1% | 121,670 | -1.1% | 0.02% | +14.3% |
| Q2 2022 | $8,549,000 | -19.1% | 123,010 | -3.6% | 0.02% | +5.0% |
| Q1 2022 | $10,573,000 | +10.4% | 127,617 | +0.1% | 0.02% | +17.6% |
| Q4 2021 | $9,575,000 | -35.2% | 127,524 | +0.3% | 0.02% | -41.4% |
| Q3 2021 | $14,768,000 | -48.8% | 127,126 | -2.2% | 0.03% | -46.3% |
| Q2 2021 | $28,845,000 | +66.9% | 130,037 | -0.6% | 0.05% | +58.8% |
| Q1 2021 | $17,284,000 | -25.2% | 130,762 | -2.1% | 0.03% | -27.7% |
| Q4 2020 | $23,104,000 | +84.8% | 133,519 | +18.9% | 0.05% | +67.9% |
| Q3 2020 | $12,502,000 | +92.5% | 112,319 | +2.5% | 0.03% | +75.0% |
| Q2 2020 | $6,496,000 | +141.0% | 109,539 | +173.7% | 0.02% | +100.0% |
| Q1 2020 | $2,695,000 | -19.8% | 40,020 | +0.4% | 0.01% | 0.0% |
| Q4 2019 | $3,360,000 | +12.1% | 39,870 | -0.5% | 0.01% | 0.0% |
| Q3 2019 | $2,997,000 | +18.3% | 40,080 | 0.0% | 0.01% | +14.3% |
| Q2 2019 | $2,534,000 | +46.2% | 40,080 | +11.4% | 0.01% | +40.0% |
| Q1 2019 | $1,733,000 | +48.1% | 35,980 | +2.9% | 0.01% | +66.7% |
| Q4 2018 | $1,170,000 | -28.9% | 34,960 | +11.3% | 0.00% | -25.0% |
| Q3 2018 | $1,645,000 | +69.6% | 31,397 | +1.4% | 0.00% | +33.3% |
| Q2 2018 | $970,000 | +48.1% | 30,977 | +3.0% | 0.00% | +50.0% |
| Q1 2018 | $655,000 | +9.7% | 30,067 | +1.7% | 0.00% | 0.0% |
| Q4 2017 | $597,000 | +1.7% | 29,565 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $587,000 | +41.8% | 29,565 | +23.4% | 0.00% | +100.0% |
| Q2 2017 | $414,000 | +150.9% | 23,955 | +17.5% | 0.00% | – |
| Q1 2017 | $165,000 | +3.1% | 20,385 | 0.0% | 0.00% | – |
| Q4 2016 | $160,000 | -8.0% | 20,385 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $174,000 | – | 20,385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |